Program notes:

0:37 Breast density knowledge outcomes

1:37 Breast density notification and education

2:37 Can't assess the import individually

3:30 CV outcomes with tirzepatide

4:30 HbA1c 8.4

5:30 GLP-1s have many benefits

6:30 No difference in adverse events

7:10 Covid vaccination in pregnancy

8:10 20K women included

9:10 Initial benefit is it durable?

9:30 Complex regional pain syndrome treatment

10:30 Using bisphosphonates for treatment

11:33 Even light contact causes severe pain

12:28 End

Program notes:

0:35 Should surgery efficacy

1:30 10-year follow of ASD surgery

2:30 Exercise does relieve pain

3:00 Association of pain with intrinsic capacity and inflammation

4:00 Domains including locomotion and others

5:01 Pain impacts a number of capacities

6:01 Aspirational to figure out pain

6:30 Scheduling birth at term to avoid preeclampsia

7:30 High-risk pregnancy delivered at term

8:35 Is there impact on the infants?

9:18 AI decision support for large-vessel stroke

10:20 71,000+ patients with ischemic stroke

11:25 U.S. data also not impressive

12:54 End

Program notes:

0:35 Update on RSV, flu and COVID-19 vaccines

1:35 500 studies included

2:35 Rare myocarditis

3:35 Flu vaccine in older adults

4:30 Tai chi or CBT-I for chronic insomnia

5:30 Trained in one or the other

6:30 Inexpensive and accessible

7:30 $150 billion cost of chronic insomnia

7:45 GLP-1s and WHO guidance

8:50 Multimodal approach required

9:45 Prevention is important

9:55 Corticosteroids in pregnancy

10:50 1.3 million pregnancies

11:50 Used for multiple indications

12:46 End

Program notes:

0:40 CVD risk factors and texting

1:40 How many undergo screening?

2:41 Impact of personalized messaging

3:25 Decentralized trials versus centralized 

4:25 Decentralized much larger

5:25 Does the trial move in one way or another?

6:15 Two studies related to use of peripregnancy GLP-1 use

7:15 Stopping at pregnancy

8:15 Is overweight worse than stopping?

9:00 Machine learning model, tissues, genetics and age

10:00 Practical for assessing genetic basis

11:00 Sequential tissue samples

11:57 End

Program notes:

1:25 mRNA flu vaccine

2:25 Phase three trial

3:25 Preventing infection with a respiratory virus

4:25 Prophylaxis with NSAID?

4:45 Umbrella review of acetaminophen in pregnancy, ASD and ADHD

5:42 Confidence was low to critically low

6:45 Other factors such as environmental exposures

7:22 Increasing potassium to prevent heart arrythmias

8:33 Increase with supplements or dietary advice

9:18 Canceling funding for clinical trials

10:18 In the process of receiving interventions

11:18 Can't not analyze 

12:15 End

Program notes:

0:50 Fish oil supplements and hemodialysis

1:50 1200 individuals to fish oil or not

2:50 Needs another study

3:11 PCSK9 inhibitor in people without MI or stroke

4:13 3- or 4-point MACE

5:11 Getting LDL down helps

6:11 Addition of more than one oral agent

6:50 Right therapy for afib and a stent

7:50 Noninferiority trial

8:50 After 12 months single agent works

9:27 Anticoagulation after afib tx

10:30 Low primary safety outcomes

11:25 96% won't have a stroke

12:16 End

Program notes:

0:37 An oral med for obesity

1:37 Five to 10% stopped medication

2:35 Need head-to-head trials with injectable

3:00 Stem cell infusion after MI and heart failure

4:01 Reduced heart failure in recipients

5:01 Twice as many in the control arm

6:01 Moving past BMI in predicting atherosclerosis

7:01 Especially in overweight but not obese

8:01 Almost 3000 participants in Brazil

8:25 Blood samples precede MS

9:04 Seen seven years beforehand

10:02 Twin studies and relatives

11:03 Way to intervene earlier

11:15 Applaud OpenAI

13:00 End

Program notes:

0:45 Steps, more and longer?

1:45 8,000 steps or less

2:45 Nothing on intensity

3:30 Mediterranean diet for IBS

4:30 Reduction in IBS symptom severity scale

5:30 Easy to accommodate with high compliance

6:30 Exercise for knee osteoarthritis

7:30 All types of exercise examined

8:30 Initiated exercise to try to address

9:00 AI intervention in prediabetes

10:00 Based on diabetes prevention program

11:00 AI and human led essentially the same

12:00 99% of eligible group don't have access

13:09 End

Program notes:

0:40 Nicotine reduction for various subgroups

1:40 Native American and Alaskan populations benefit most

2:42 Black, rural populations 10 million lives saved

3:40 19-39 million life years saved

4:00 Food insecurity and blood pressure

5:00 Food vouchers most successful

6:00 May be more involved and motivated

6:35 PFAS and infant brain architecture

7:35 Children assessed with MRI

8:30 Didn't correct for various factors

9:31 Other types of plasticized chemicals

9:50 Afib after cardiac surgery

10:50 Only found with implantable monitor

11:50 Very short duration of afib

12:51 End

Program notes:

0:40 New drug for SLE

1:41 Monitored for a year

2:43 Only one pathway limited

3:00 AI and health care

4:00 How to assure compliance?

5:00 Policy changes needed

6:01 Pessimistic about oversight

6:50 Genetic treatment for ADA deficiency

7:50 Using a viral vector

8:50 A curative treatment

9:30 Social media and cognitive performance in adolescents

10:30 Low and high increasing social media use

11:30 Good enough evidence

12:31 End